Cannabis is arguably one of the most talked about – but
turbulent – markets in recent times.
Although there are rumblings on the cannabis market throughout
the world, it is without doubt that Canada and the US are the focus
of investor attention.
Top of mind for investors is the potential passage of US federal
law, making it "open season" for expansion of the
recreational and medical markets. Until then, in the US, there is
significant future uncertainty burdening this fascinating but
falteringly fragmented sector.
Notwithstanding the apparent slowing in the North American
cannabis markets reported of late, the US journey has been
groundbreaking. California passed the Compassionate Use
Act back in 1996, effectively legalizing medical cannabis.
Fast forward to today, 33 states have legalized medical cannabis at
some level and 11 states (and Washington DC) have legalized both
uses.
